Skip to main content

Tebentafusp-tebn

(teh-BEN-tah-fusp)

This page contains brief information about tebentafusp-tebn and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Kimmtrak
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tebentafusp-tebn is approved to treat:

  • Uveal melanoma that cannot be removed by surgery or has spread to other parts of the body. It is used in adults who have the HLA-A*02:01 antigen.

Tebentafusp-tebn is also being studied in the treatment of other types of cancer.

More About Tebentafusp-tebn

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Tebentafusp-tebn - Information about the use of this drug to treat cancer.

Research Results and Related Resources

Immunotherapy Drug Tebentafusp Improves Survival in Advanced Uveal Melanoma

Clinical Trials Accepting Patients

Find Clinical Trials for Tebentafusp-tebn - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: